EquityZen Growth Technology Fund LLC - Series 232
Raised
$306K
Investors
20
Min Invest
$10,003
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 232 is a Delaware-domiciled pooled investment fund filed by EquityZen Advisors LLC on 2018-07-03. The vehicle raised $306K from 20 investors with a $10K minimum investment, relying on Regulation D Rule 506(b) and 3(c)(1) exemptions. This is one of approximately 1,891 related EDGAR entities associated with the EquityZen pre-IPO platform.
This pre-IPO fund represents a typical EquityZen structure: a single-series pooled vehicle offering access to private-company equity with a low ($10K) minimum investment threshold. The 506(b) exemption with 3(c)(1) status is standard for sub-100 investor private funds targeting accredited individuals, and the investor-to-capital ratio ($15.3K average commitment) aligns with the platform's retail-oriented model for pre-IPO exposure.
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Shriram Bhashyam
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.